The relative virulence was determined for 14 species of aspergilli, by inoculating normal mice intravenously with graded doses of spores. Eleven were found to possess some degree of virulence, whereas three others were avirulent. Members of the Aspergillusflavus group were the only species that consistently killed mice with doses as low as 104 viable spores. When the in vivo fate of spores was compared for a virulent and an avirulent strain of Aspergillus, spores of the latter were cleared rapidly from the liver and spleen but grew in the kidneys and brain, producing progressive disease. Mice which inhaled spores did not succumb, but macrophages washed from their lungs contained spores. A relationship of virulence to spore characteristics such as germination time, size, shape, and external markings could not be established. Virulence could not be related to aflatoxin production inasmuch as at least one virulent strain did not produce aflatoxin in vitro.
The aflatoxin-producing characteristics were as follows: A. flavus 38, and A. parasitucus were shown to produce aflatoxin B, in vitro at both 26 and 37 C, although the amount produced at 37 C was less than that at 26 C. A. tamarii, A. oryzae, and A. clavatus failed to produce aflatoxin, as detectable by chromatographic methods (2) , at either temperature when cultured on wheat cereal or Sabouraud agar (6) . The other cultures were not tested.
Cultures were grown in petri plates containing Sabouraud Dextrose Agar (Difco) for 4 days at 37 C. Species which grew but did not sporulate well at this temperature were grown at 26 C for 9 days. The matured cultures were dried for an additional 2 days at 37 C by replacing glass covers with porous asbestos tops. Spores from each strain were collected by inverting the cultures and tapping gently. Some of the spores were used in the dry state to produce aerosols for respiratory infection. For a study of virulence by the parenteral route, spores were suspended in phosphate-buffered saline (pH 7.2) by shaking with glass beads, then were filtered through glass wool and stored at 4 C while estimation of viable spore concentration was being made. Counting was facilitated by use of pour plates prepared with Littman's medium; rapidly spreading growth was prevented and discrete colonies formed. Maximal counts were 928 on October 16, 2017 by guest http://jb.asm.org/ EXPERIMENTAL ASPERGILLOSIS apparent after 2 days of incubation at 37 C. During this period, the viability of the stored suspensions did not change, as determined by plate counts. Killed spores, used as controls, were obtained by heating a suspension at 80 C in a water bath for 20 min. All suspensions were shown to be free from bacterial contamination by culturing on blood agar. Fresh suspensions were prepared for each experiment.
Determiniation of pathogenicity. Male CF1 mice, 20 to 25 g, were used in all experiments. The usual period of observation was 21 days, although parts of some groups were held 6 months or longer.
Nine aerosol exposure studies were performed by use of 8 to 18 cortisone-pretreated mice in each; no normal mice were exposed. After 20 min of exposure to spore clouds generated (9) from 400 mg of dry A. fumigatus C61 spores, three animals per experiment were sacrificed to determine the inhaled dose. The lungs of each mouse were homogenized separately, and pour plates were made. On the basis of these plate counts, a calculated 105 to 5 X 106 viable units reached the pulmonary bed. In six of the experiments, the calculated dose was 4 X 106 per mouse. In two experiments, three to six mice were sacrificed 1.5 hr after exposure; macrophages were washed from the lungs, and Giemsa-stained preparations were examined for the presence of spores.
Groups of 20 mice were inoculated via the lateral tail vein with 0.5 ml of suspension, prepared from each culture and containing 102, 104, or 106 viable units per ml. In one experiment, a group of cortisone-pretreated mice were included as a control, otherwise all mice were without prior treatment. In another experiment, controls were inoculated with a heat-killed suspension derived from the suspension containing 106 viable units per ml. The number of viable units was determined at the beginning and end of each series of animal inoculations by preparing triplicate pour plates of the highest dilution. All counts agreed within ±+-5% of the estimated concentration.
In those experiments in which mice were pretreated, 5 mg of cortisone acetate was given subcutaneously 2 days before infection; antibiotic protection was instituted at the same time (9) .
To determine the fate of spores after intravenous inoculation, mice were inoculated with 104 viable spores of A. clavatus (avirulent) or A. flavus 38 (virulent) and were sacrificed at intervals during 30 days. The lungs, liver, spleen, kidneys, and brain were homogenized individually, and total viable fungal counts were determined by duplicate pour plates.
To detect possible differences in rates of phagocytosis of spores from strains of differing virulence, animals were inoculated intraperitoneally with A.
clavatus or A. flavus 38. The peritoneal cavities were washed 1 to 3 hr later, and the macrophages were examined after staining with Giemsa.
In vitro spore studies. To determine whether retardation of growth at body temperature could account for lack of virulence, the rate of growth of A. clavatus (avirulent species) was determined at 25, 37, and 40 C. A. flavus 38, a virulent species, was used as a parallel control-Spores were inoculated onto pinpoint areas of Sabouraud agar plates, and colony size was recorded after 12, 24, and 48 hr of incubation. Spore germination time and the effect of pH on germination also were determined at 37 and 40 C, by use of the method of Goos (4) .
For all strains, the size of suspended spores was measured with an optical micrometer. Any external markings were noted.
RESULTS
Normal mice proved to be susceptible to most of the species of aspergilli inoculated intravenously (Fig. 1) ; cortisone pretreatment, although greatly enhancing disease, was not necessary to ensure infection. Variation in virulence was demonstrated best, however, by response to graded doses. All species, except A. clavatus, A. candidus, and A. flavipes, killed mice when 106 spores were inoculated intravenously, but A. parasiticus, A. oryzae, A. tamarii, and A. flavus, irrespective of strain, proved to be the most virulent inasmuch as only they consistently killed mice at the lower dose level of 104 spores. None of the aspergilli caused death when only 102 spores were inoculated. A. clavatus was further tested in cortisonepretreated mice and still did not exhibit virulence; the spores often remained viable in the tissues, but there was no evidence of fungal growth.
An experiment with A. flavus 38 was repeated several times, and there was always 100% mortality within 5 days for mice inoculated with 106 viable spores. With inoculation of 104 spores, mortality ranged from 15 to 75%, with 38% as the average in nine separate experiments. The time till death, however, was less variable since the period of greatest mortality after inoculation with 104 spores was always between 5 and 10 days after inoculation, irrespective of total deaths. Animals surviving this critical 10-day period usually did not die. A chronic disease was observed, however, in some of the mice held for prolonged observation, since a few deaths occurred several months after inoculation. There was no indication of disease other than aspergillosis.
Cultures and direct microscopic examination of various organs from the animals that died within 10 days showed fungal proliferation only in the kidneys and brains. Mice that died several months after inoculation usually had one diseased kidney, but other organs, including brains, were always free from fungus.
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DISCUSSION
The most interesting observation in these studies was the difference in capacity of different organs to eliminate spores of varying virulence. The lung rapidly disposed of spores, regardless of the pathogenic potential of the fungal isolate and regardless of the route of exposure. In the case of liver and spleen, however, only spores of virulent isolates were removed; the host seemed unable to rid these tissues of avirulent spores. Spores of an avirulent aspergillus, although lacking capacity to germinate in liver and spleen, were able to survive, viable but dormant, for long periods of time. This failure to germinate may actually have served as the mechanism of spore survival. It was found that, before germination on agar, spores increased approximately twofold in diameter, presumably by absorption of liquid from the surrounding milieu. If, then, only the virulent species tried to germinate in vivo, and if germination were accompanied by increased swelling and permeability, such spores might, especially if phagocytized, absorb substances destructive to the fungus. It was this thinking that led to our in vitro studies on germination at low pH, for it has been shown that phagocytized particles are often enclosed within a cell vacuole which is strongly acidic (7). Germinating spores, however, irrespective of virulence, were not killed by low pH. These negative results do not invalidate the hypothesis that avirulent spores may have been protected from in vivo destructive forces by their intact spore walls and, conversely, that spores of virulent isolates became vulnerable during the process of germination because killing could have been effected by other than pH changes. However, regardless of the mechanism of defense of liver, lung, and spleen against spores of a virulent species, this defense was not operative at other sites, viz., kidney and brain, for there was extensive proliferation, resulting in eventual death of the animal.
It is tempting to relate roughness of spore wall with virulence, for most of the virulent strains had echinulate walls, whereas most of the avirulent ones had smooth walls. However, echinulation cannot be the sole factor related to virulence, since two species of relatively low virulence had rough to echinulate spores. Ability to grow at various temperatures also was considered in relation to virulence, but no correlation could be found. All species used in these studies grew well at 37 C. A. fumigatus, on the other hand, which has been shown by others (8) to grow at temperatures of 40 C and above, was of relatively low mouse virulence.
Toxin production also warrants consideration as a factor determining the pathogenicity of aspergilli. Symmers (10) stated that "diffusion necrosis" often seen in pulmonary aspergillosis is possibly caused by toxic products of the fungus.
Also, the role of diffusible toxic metabolites of aspergilli in tissue necrosis and vascular damage was stressed by Gowing and Hamlin (5). Furthermore, it is known that toxic substances can be extracted from the mycelia of certain species. This latter aspect was not explored in our study, although it is to be noted that two of the virulent strains used, A. flavus 38 and A. fumigatus 105, were found by others (11) to have extractable toxic material. Thus, it is not possible to eliminate the role of such substances in pathogenicity.
Several other toxic metabolites are produced by A. flavus, e.g., oxalic acid, kojic acid, tremorgenic substance, ,-nitro-propionic acid, and aflatoxins, all of which have been reviewed by Wilson (12) and Wogan (13) . It was determined that at least one of the strains of A. flavus used in our study produces aflatoxin in vitro at 37 C. However, two other virulent members of the A. flavus group, A. tamarii and A. oryzae, failed to produce aflatoxins. Attempts were made to determine whether aflatoxins were produced in situ in our experimental animals, but the results were uniformly negative. Admittedly, further work is needed before definite conclusions can be made, but there are points which count against aflatoxin having a significant role in experimental murine aspergillosis. First, as stated above, two virulent aspergilli failed to produce aflatoxin in vitro, and this observation is strengthened by the work of Hesseltine et al. (6) , who reported that none of 53 isolates of A. oryzae produced afla-
